In a PET study of medication naïve adults with ADHD taking MPH for 12 months (compared with controls), it was shown that there was a significant increase (+24%, p < 0.01) in striatal dopamine transporter availability in the caudate, putamen, and ventral striatum [14]. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.